Gynecologic oncology

Keyphrases

Publications

volume 191, 2024

Sara Moufarrij, Andrea Gazzo, Satshil Rana, Pier Selenica, Nadeem R Abu-Rustum, Lora H Ellenson, Ying L Liu, Britta Weigelt, Amir Momeni-Boroujeni
Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification. Gynecologic oncology 191 (2024)
Mary Katherine Anastasio, Angela Nolin, Katherine N Penvose, Katherine Lambert, Jessie Li, Leila Ledbetter, Brittany A Davidson, Laura J Havrilesky, Benjamin B Albright
Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis. Gynecologic oncology 191 (2024)

volume 190, 2024

Christina A Metcalf, Chloe E Page, Brianna O S Stocker, Rachel L Johnson, Korrina A Duffy, Mary D Sammel, James Loughead, C Neill Epperson
Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine. Gynecologic oncology 190 (2024)
Chenxue Qi, Mengmeng Lyu, Zhipeng Yao, Fan Zhang, Yan Zhu, Min Qi, Xiaoxiang Cao, Congzhu Li, Hongping Xia, Dongfang Dai
SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway. Gynecologic oncology 190 (2024)
Courtney J Riedinger, Julia Sakach, Jill M Maples, Jessica Fulton, Jessica Chippior, Benjamin O'Donnell, David M O'Malley, Laura M Chambers
Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist. Gynecologic oncology 190 (2024)
M Yunokawa, N Kurihara, N Ishizuka, H Kanao, H Kajiyama, M Shimada, A Okamoto, D Aoki, T Sugiyama, T Enomoto
Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3. Gynecologic oncology 190 (2024)
Elizabeth Chuk, Jessica L Conway, Jennifer Hanuschak, Kathy Han, Michael Milosevic, Jelena Lukovic, Sarah E Ferguson, Ailya Salman, Anna T Santiago, Alexandra Rink, Jennifer Croke
Patient-reported sexual health outcomes of cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy. Gynecologic oncology 190 (2024)
Benjamin Grant, Alex Raghunandan, Emily Epstein, Jesse T Brewer, Isabelle Chandler, Taylor Larosa, Alissa Kalyan, Sarah Schulman, Ashley Llenas, Eloise Chapman-Davis, Charlene Thomas, Paul Christos, Steven M Lipkin, Ravi N Sharaf, Melissa K Frey
Timely targeted testing for hereditary cancer syndromes - Importance of clinician-facilitated cascade testing in the first year post-diagnosis. Gynecologic oncology 190 (2024)
Eric Rios-Doria, Silvana Pedra Nobre, Dib Sassine, Gretchen Glaser, Ane Gerda Eriksson, Beyhan Ataseven, Andreas du Bois, Vicky Makker, Kaled Alektiar, Mario M Leitao, Nadeem R Abu-Rustum, Jennifer J Mueller
Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium. Gynecologic oncology 190 (2024)
Mayu Shibata, Kosuke Yoshida, Akira Yokoi, Hironori Suzuki, Yusuke Yamamoto, Masami Kitagawa, Eri Asano-Inami, Yuko Yasui, Yuki Nishiko, Masato Yoshihara, Satoshi Tamauchi, Nobuhisa Yoshikawa, Kimihiro Nishino, Eiko Yamamoto, Kaoru Niimi, Hiroaki Kajiyama
Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq. Gynecologic oncology 190 (2024)
Emily A Miller, Bhoomika Chowdhary, Eloise Chapman-Davis
Beyond the decision: Reproductive justice and cervical cancer care in a post-Dobbs era. Gynecologic oncology 190 (2024)
Akira Yokoi, Hiroko Machida, Muneaki Shimada, Koji Mastuo, Shogo Shigeta, Shigenori Furukawa, Nobumichi Nishikawa, Hiroyuki Nomura, Kensuke Hori, Hideki Tokunaga, Tadahiro Shoji, Tsukasa Baba, Satoru Nagase
Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis. Gynecologic oncology 190 (2024)
C Heus, S Stelten, G G Kenter, L M Buffart, L R C W van Lonkhuijzen
Body composition and peri- and postoperative complications in patients with gynaecological malignancies: A systematic review. Gynecologic oncology 190 (2024)
Mayumi Kobayashi Kato, Erisa Fujii, Maiko Yamaguchi, Daiki Higuchi, Yuka Asami, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Koji Matumoto, Tomoyasu Kato, Takashi Kohno, Mitsuya Ishikawa, Kouya Shiraishi, Hiroshi Yoshida
Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma. Gynecologic oncology 190 (2024)
Mackenzie Lemieux, Rachel Telles, Michael Goodheart, Laila Dahmoush, Ian Hagemann, Frank J Penedo, Renu Nandakumar, Steve W Cole, Anil K Sood, Susan K Lutgendorf, Premal H Thaker
Quality of life and survivorship in patients with low-grade ovarian cancer. Gynecologic oncology 190 (2024)
Syem K Barakzai, Amy J Bregar, Marcela G Del Carmen, Eric L Eisenhauer, Annekathryn Goodman, Jose A Rauh-Hain, Allison A Gockley, Alexander Melamed
The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study. Gynecologic oncology 190 (2024)
Deepti Jain, Fadi Zaeim, Marya Wahidi, William J Smith, Waed Alkaram, Asem Abu-Jamea, Sanaa Awada, Lien Hoang, Anna Pesci, Ricardo R Lastra, Takako Kiyokawa, Esther Oliva, Kyle Devins, Hyejeong Jang, Seongho Kim, Terrence Wong, Radhika Gogoi, Robert Morris, Claudia Mateoiu, Sudeshna Bandyopadhyay, Simona Stolnicu, Robert Soslow, Rouba Ali-Fehmi
Cervical squamous cell carcinoma outcomes across continents: A retrospective study. Gynecologic oncology 190 (2024)
Chen Nahshon, Mario M Leitao, Yakir Segev
Response to the letter to the editor: Referring to the manuscript entitled "Surgical nodal assessment for endometrial hyperplasia - A meta-analysis and systematic review". Gynecologic oncology 190 (2024)
Yoo Kyung Choi, Jong Hoon Lee, Yeon Sil Kim, Chan Woo Wee, Yong Bae Kim, Sang Joon Park, Wonguen Jung, Ki Ho Seol, Euncheol Choi
Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03. Gynecologic oncology 190 (2024)
Matthew K Wagar, Ushma J Patel, Kharmen Bharucha, Christine A Heisler, Megan F Peterson, Amy Godecker, Sumer K Wallace, Ryan J Spencer
Postoperative urinary retention by void trial methodology following radical hysterectomy for cervical cancer. Gynecologic oncology 190 (2024)
Ricarda Merten, Vratislav Strnad, Andre Karius, Michael Lotter, Stephan Kreppner, Claudia Schweizer, Rainer Fietkau, Philipp Schubert
Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience. Gynecologic oncology 190 (2024)
Hyunji Lim, Se Ik Kim, Min Kyung Kim, Soon Ho Yoon, Maria Lee, Dong Hoon Suh, Hee Seung Kim, Kidong Kim, Jae Hong No, Hyun Hoon Chung, Yong Beom Kim, Noh Hyun Park, Jae-Weon Kim
Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study. Gynecologic oncology 190 (2024)
Yukio Suzuki, Ling Chen, Koji Matsuo, Jennifer S Ferris, Elena B Elkin, Alexander Melamed, Chung Yin Kong, Nina Bickell, Evan R Myers, Laura J Havrilesky, Xiao Xu, Stephanie V Blank, William D Hazelton, Dawn L Hershman, Jason D Wright
Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecologic oncology 190 (2024)
B Pothuri, Z Sawaged, H C Karpel, X Li, J Lee, F Musa, K Lutz, E Reese, S V Blank, L R Boyd, J P Curtin, J D Goldberg, F M Muggia
A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus. Gynecologic oncology 190 (2024)
Narissa J Nonzee, Heike Thiel de Bocanegra, Sandy Navarro, Roshan Bastani, Beth A Glenn, Gerald F Kominski, Anna-Barbara Moscicki
Impact of management guidelines for abnormal cervical cytology on colposcopy procedure rates among young women. Gynecologic oncology 190 (2024)
Lenka Fricová, Stefan Kommoss, Giovanni Scambia, Gwenael Ferron, Roman Kocián, Philipp Harter, Luigi Pedone Anchora, Anne-Sophie Bats, Zoltán Novàk, Christina Barbara Walter, Francesco Raspagliesi, Eric Lambaudie, Kiarash Bahrehmand, Jürgen Andress, Jaroslav Klát, Jana Pasternak, Olga Matylevich, Nina Szeterlak, Luboš Minář, Florian Heitz, Mihai Emil Căpîlna, Ingo Runnebaum, David Cibula, Jiří Sláma
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study. Gynecologic oncology 190 (2024)
Yu Gu, Yang Liu, Hongyan Cheng, Wenze Wang, Xiaowei Xue, Xirun Wan, Fengzhi Feng, Junjun Yang, Tong Ren, Jun Zhao, Fang Jiang, Yuan Li, Yang Xiang
Clinicopathological characteristics and oncologic outcomes of patients with gestational trophoblastic neoplasia manifesting as isolated pulmonary lesions. Gynecologic oncology 190 (2024)
James W Webber, Laura Wollborn, Sudhanshu Mishra, Allison F Vitonis, Daniel W Cramer, Ryan T Phan, Todd C Pappas, Konrad Stawiski, Wojciech Fendler, Dipanjan Chowdhury, Kevin M Elias
Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass. Gynecologic oncology 190 (2024)
Tanya L Ross, Renhua Na, George Au-Yeung, Anna DeFazio, Michael Friedlander, Tharani Sivakumaran, Karen Livingstone, Christina M Nagle, Hélène O'Neill, Merran Williams, Penelope M Webb, Vanessa L Beesley
Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival? Gynecologic oncology 190 (2024)
Erik Škof, Vida Stegel, Vita Šetrajčič Dragoš, Ana Blatnik, Brigita Gregorič, Petra Škerl, Gašper Klančar, Anja Zagožen Klasinc, Alenka Bombač, Mateja Krajc, Srdjan Novaković
Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report. Gynecologic oncology 190 (2024)
Christina A Metcalf, Chloe E Page, Brianna O S Stocker, Rachel L Johnson, Korrina A Duffy, Mary D Sammel, James Loughead, C Neill Epperson
Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine. Gynecologic oncology 190 (2024)
Charlotte R Gamble, Yongmei Huang, James Quinn, Alexander Melamed, Andrew Rundle, Jason D Wright
Neighborhood economic vulnerability as a predictor for patterns of care and outcomes for patients with uterine cancer. Gynecologic oncology 190 (2024)
Corrine A Nief, Sara E Long, Tamra-Lee McCleary, Elizabeth Kidd, Babak Litkouhi, Brooke Howitt
Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study. Gynecologic oncology 190 (2024)
Stuart A Ostby, Deepa Narasimhulu, Michelle A Ochs Kinney, William Cliby, Carrie Langstraat, Jamie N Bakkum-Gamez, Karen Ishitani, Maureen Lemens, Peter Martin, Bijan Borah, James Moriarty, Gretchen Glaser, Amanika Kumar, Katherine W Arendt, Sean C Dowdy
Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial. Gynecologic oncology 190 (2024)
L Proppe, A Jaeger, Y Goy, C Petersen, A Kruell, K Prieske, B Schmalfeldt, V Mueller, L Woelber
Systematic review - Adjuvant radiotherapy of the vulva in primary vulvar cancer. Gynecologic oncology 190 (2024)
Jubilee Brown, Austin Miller, Laura L Holman, Floor Backes, Christa Nagel, David Bender, David S Miller, Matthew A Powell, Shannon N Westin, Albert Bonebrake, Carolyn Y Muller, Angeles Alvarez Secord, Erin Crane, John Schorge, William P Tew, Anil K Sood, Michael A Bookman, Carol Aghajanian, David M Gershenson
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14. Gynecologic oncology 190 (2024)
Naomi N Adjei, Allen Haas, Hui Zhao, Kristin M Primm, Sharon H Giordano, Charlotte C Sun, Larissa A Meyer
Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021. Gynecologic oncology 190 (2024)
Ruth Fullerton, Kevin Martell, Rutvij Khanolkar, Tien Phan, Robyn Banerjee, Tyler Meyer, Laurel Traptow, Martin Köbel, Prafull Ghatage, Corinne M Doll
Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy. Gynecologic oncology 190 (2024)
Shilpa Mokshagundam, Michaela E McGree, Amanda L Tapia, Angela J Fought, Karen P Ishitani, Minji K Lee, Sean C Dowdy, Siddhartha Yadav, Deirdre R Pachman, Amanika Kumar
Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancer. Gynecologic oncology 190 (2024)
Linh Nguyen, Tong Han Chung, Yen-Chi L Le, Hannah Reygaerts, Xochitl Olguin, Abigail Zamorano
Hispanic individuals' cervical cancer screening disparities amidst the COVID-19 pandemic. Gynecologic oncology 190 (2024)
Alexandria N Young, Lawrence H Lin, Mary Kathryn Abel, Marika Osterbur Badhey, Adam Lechner, Neil S Horowitz, Ross S Berkowitz, Carlos Parra-Herran, Kevin M Elias
Atypical placental site nodules: Clinicopathologic features, management and patient outcomes in an institutional series. Gynecologic oncology 190 (2024)
Clare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, Ashwini Joshi, Maria Pisu, Margaret I Liang, Kevin C Ward, Margaret Gates Kuliszewski, Thomas Tucker, Andrew Berchuck, Bin Huang, Tomi Akinyemiju
Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity. Gynecologic oncology 190 (2024)
Rosa A Guerra, Celia Kaplan, Hala Borno, John Boscardin, Edwin A Alvarez, Ann Lazar, Jocelyn Chapman, Megan Swanson, Stephanie Ueda, Lee-May Chen
The role of race/ethnicity and age in clinical trial knowledge among patients with gynecologic malignancy. Gynecologic oncology 190 (2024)
Xin Ray Tee, Emma Hazard, Elena Latorre-Esteves, Brendan F Kohrn, Talayeh S Ghezelayagh, Jeanne Uy Fredrickson, CoohleenAnn Coombes, Marc R Radke, Enna Manhardt, Ronit Katz, T Rinda Soong, Elizabeth M Swisher, Barbara M Norquist, Rosa Ana Risques
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations. Gynecologic oncology 190 (2024)

volume 189, 2024

Nadiha Noor Chelsea, Natalie Posever, Tina Yi Jin Hsieh, Sutania Patterson, Christine Sweeney, John L Dalrymple, Joseph Dottino, Andrew C Wiechert, Leslie Garrett, Michele R Hacker, Katharine M Esselen
Implementation of a financial navigation program in gynecologic oncology. Gynecologic oncology 189 (2024)
Babette van der Eerden, Belle H de Rooij, Leo J Schouten, Dorry Boll, Dennis van Hamont, M Caroline Vos, Nicole P M Ezendam
Quality of life among borderline ovarian tumor survivors: A comparison with survivors of early-stage ovarian cancer and a cancer-free population: A cross-sectional population-based PROFILES study. Gynecologic oncology 189 (2024)
Gry Johansen, Claudia Lampic, Angelique Flöter Rådestad, Pernilla Dahm-Kähler, Kenny A Rodriguez-Wallberg
Health-related quality of life, sexual function, psychological health, reproductive concerns and fertility outcome in young women treated with fertility-sparing surgery for ovarian tumors - A prospective longitudinal multicentre study. Gynecologic oncology 189 (2024)
Sharonne Holtzman, Caroline Gellman, Elianna Kaplowitz, Emma Barber, Warner Huh, Stephanie V Blank
Yes, it's true: Benign hysterectomy trends for gynecologic oncologists in the United States from 2015 to 2021. Gynecologic oncology 189 (2024)
Alexandre Andre B A da Costa, Ronaldo Pereira Souza, Natasha Carvalho Pandolfi, Fabrício de Souza Castro, Glauco Baiocchi, Andrea Paiva G Guimarães
Should we consider progression-free survival benefits enough for drug approvals in locally advanced cervical cancer? Gynecologic oncology 189 (2024)
Sarah P Huepenbecker, Pamela T Soliman, Larissa A Meyer, Maria D Iniesta, Gary B Chisholm, Jolyn S Taylor, Roni Nitecki Wilke, Nicole D Fleming
Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program. Gynecologic oncology 189 (2024)